Has Merck Sharp & Dohme LLC had other FDA enforcement actions?

Yes. Argus HQ has recorded 3 total FDA actions tied to Merck Sharp & Dohme LLC: 0 warning letters, 2 recalls, 1 approval record, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-07-16; Argus observed and indexed it on 2026-07-18.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_approval · nda · info

MERCK SHARP AND DOHME LLC — NDA approval: ENLICITIDE (unspecified)

Name: FDA Drug Approval Record — Merck Sharp & Dohme LLC
Creator: Argus HQ
Published: 2026-07-16
License: https://argushq.ai/methodology

Event date: 2026-07-16 00:00:00Z
Observed: 2026-07-18 04:30:40Z
Source ID: NDA220848-1
Payload hash: a8c63ca49543c2b5a1603848…

Summary

MERCK SHARP AND DOHME LLC received NDA approval for ENLICITIDE (unspecified) on 2026-07-16. Dosage form: TABLET. Application #: NDA220848.

Entities

Merck Sharp & Dohme LLC

View source record ↗

Frequently asked questions

Has Merck Sharp & Dohme LLC had other FDA enforcement actions?: Yes. Argus HQ has recorded 3 total FDA actions tied to Merck Sharp & Dohme LLC: 0 warning letters, 2 recalls, 1 approval record, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-07-16; Argus observed and indexed it on 2026-07-18.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). MERCK SHARP AND DOHME LLC — NDA approval: ENLICITIDE (unspecified). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-approval-merck-sharp-and-dohme-llc-nda220848-1

MLA

"MERCK SHARP AND DOHME LLC — NDA approval: ENLICITIDE (unspecified)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-approval-merck-sharp-and-dohme-llc-nda220848-1.

Chicago

Argus HQ Research. "MERCK SHARP AND DOHME LLC — NDA approval: ENLICITIDE (unspecified)." Digital Empire Holdings LLC. Accessed July 18, 2026. https://argushq.ai/events/fda-approval-merck-sharp-and-dohme-llc-nda220848-1.

BibTeX

@misc{argushq_argushq_ai_events_fda_approval_merck_sharp_and_dohme_llc_nda220848_1_2026,
  title = {MERCK SHARP AND DOHME LLC — NDA approval: ENLICITIDE (unspecified)},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-approval-merck-sharp-and-dohme-llc-nda220848-1},
  note = {Accessed: July 18, 2026}
}

Informational only. Not legal, financial, or medical advice.